You are here

  • Home
  • Archive
  • Volume 25, Issue Suppl 1
  • 6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): comparing national and local prescribing trends

Article metrics

Article menu
Download PDFPDF
Section 6: Education and research
6ER-010 Focus on hcv treatment based on second-generation direct-acting antiviral agents (daas-2): comparing national and local prescribing trends

 

Online download statistics by month:

Online download statistics by month: March 2018 to August 2024

AbstractFullPdf
Mar 2018203
Apr 20181400
May 2018600
Jun 20181200
Jul 2018600
Aug 2018400
Sep 2018800
Oct 20181200
Nov 2018400
Dec 2018800
Jan 2019800
Feb 2019400
Mar 20191400
Apr 2019400
May 2019400
Jun 2019200
Jul 2019600
Aug 2019600
Sep 2019200
Oct 2019800
Nov 2019200
Dec 2019200
Mar 2020400
Apr 2020200
May 20201000
Jun 2020800
Jul 20201200
Aug 2020200
Sep 2020400
Oct 20206801
Nov 2020200
Dec 2020800
Jan 20211000
Feb 2021200
Mar 2021800
Apr 2021200
Oct 2021200
Nov 20211200
Dec 2021800
Jan 2022400
Feb 2022600
Mar 20221200
Apr 2022200
May 2022600
Jun 2022400
Jul 2022600
Aug 2022601
Sep 2022200
Oct 2022800
Nov 20221200
Dec 2022400
Jan 2023601
Feb 2023800
Mar 20231000
Apr 2023200
Jul 2023800
Nov 2023800
Dec 20231200
Jan 2024400
Feb 2024600
Mar 20241400
Apr 20241400
May 20241000
Jun 2024400
Jul 2024600
Aug 2024500
Total49106